Approaches to classification and management of histologically ambiguous/ borderline / primary cutaneous melanocytic tumours

Richard A Scolyer; Stanley W. McCarthy; John F. Thompson

doi:10.1016/s0031-3025(16)33093-8

Back

Approaches to classification and management of histologically ambiguous/ borderline / primary cutaneous melanocytic tumours

Article 2011 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.

Richard A Scolyer, Rajmohan Murali, Stanley W. McCarthy, John F. Thompson

Article2016

5‐Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms

Jonathan J. Lee, Ricardo E. Vilain, Scott R. Granter, Nina R. Hu, Scott C. Bresler, Shuyun Xu, Alexander Frank, Martín C. Mihm, Robyn P.M. Saw, Christopher D.�M. Fletcher, Richard A Scolyer, Gëorge F. Murphy, Christine G. Lian

Article2007

Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors)

Rajmohan Murali, Raghwa Sharma, John F. Thompson, Jonathan R. Stretch, C. Soon Lee, Stanley W. McCarthy, Richard A Scolyer

Article2009

Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation

Adrienne Morey, Rajmohan Murali, Stanley W. McCarthy, Graham J. Mann, Richard A Scolyer

Article1991

Risk Factors for Epithelial Ovarian Tumours of Borderline Malignancy

Fabio Parazzini, Carlo Restelli, Carlo La Vecchia, Eva Negri, Stefania Chiari, RENATO MAGGI, Costantino Mangioni